Dr. Eva Morschl is an immunologist and scientific consultant. She holds a doctorate in Medical Sciences and Physiology and a bachelor’s degree in Molecular Biology and Biotechnology.

Dr. Morschl has 20 years of experience in developing transgenic and pharmacological mouse models as well as cell-based and biochemical assays to investigate mechanisms and treatment options for gastrointestinal, cardiovascular, or lung diseases and cancer.

During the past 8 years, Dr. Morschl has been involved in the development of cutting-edge cell therapies utilizing the latest technologies.

Dr. Morschl maintains compliance with regulatory and safety guidelines, writes standard operating procedures, and provides training to employees. She has authored and co-authored numerous peer-reviewed articles, presented at national and international meetings and received awards.

Dr. Morschl also has experience in health-risk assessments and evaluating the toxicity of a variety of chemicals (pollutants, illicit and prescription drugs, and alcohol). Additionally, Dr. Morschl has provided opinions in several insurance claims involving pharmaceuticals and medical equipment based on the evaluation of the regulatory and biochemical aspects.